DrugCite
Search

METHYLPREDNISOLONE SODIUM SUCCINATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Methylprednisolone Sodium Succinate Adverse Events Reported to the FDA Over Time

How are Methylprednisolone Sodium Succinate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Methylprednisolone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Methylprednisolone Sodium Succinate is flagged as the suspect drug causing the adverse event.

Most Common Methylprednisolone Sodium Succinate Adverse Events Reported to the FDA

What are the most common Methylprednisolone Sodium Succinate adverse events reported to the FDA?

Dyspnoea
269 (1.47%)
Pyrexia
188 (1.03%)
Condition Aggravated
146 (.8%)
Nausea
138 (.75%)
Thrombocytopenia
138 (.75%)
Multiple Sclerosis Relapse
132 (.72%)
Osteonecrosis
124 (.68%)
Hypersensitivity
123 (.67%)
Vomiting
123 (.67%)
Pruritus
115 (.63%)
Erythema
114 (.62%)
Show More Show More
Anaphylactic Shock
113 (.62%)
Drug Ineffective
111 (.61%)
Malaise
110 (.6%)
Respiratory Failure
109 (.6%)
Headache
106 (.58%)
Asthenia
103 (.56%)
Rash
103 (.56%)
Sepsis
100 (.55%)
Urticaria
99 (.54%)
Abdominal Pain
96 (.52%)
Pneumonia
94 (.51%)
Convulsion
93 (.51%)
Hypotension
93 (.51%)
Diabetes Mellitus
91 (.5%)
Hypertension
91 (.5%)
Multi-organ Failure
91 (.5%)
Loss Of Consciousness
90 (.49%)
Multiple Sclerosis
89 (.49%)
Diarrhoea
88 (.48%)
Interstitial Lung Disease
87 (.48%)
Anaemia
83 (.45%)
Anaphylactic Reaction
83 (.45%)
Shock
81 (.44%)
Blood Pressure Increased
78 (.43%)
Chest Pain
77 (.42%)
Fatigue
74 (.4%)
Oxygen Saturation Decreased
74 (.4%)
Blood Glucose Increased
73 (.4%)
Tachycardia
73 (.4%)
Renal Failure
70 (.38%)
Blood Pressure Decreased
69 (.38%)
Tremor
69 (.38%)
Chills
68 (.37%)
Aspartate Aminotransferase Increase...
67 (.37%)
Cardiac Arrest
67 (.37%)
Hyperglycaemia
67 (.37%)
Pain
66 (.36%)
Renal Failure Acute
66 (.36%)
Alanine Aminotransferase Increased
65 (.36%)
Bradycardia
65 (.36%)
Confusional State
65 (.36%)
Dizziness
64 (.35%)
Anxiety
63 (.34%)
Flushing
63 (.34%)
Hepatic Function Abnormal
63 (.34%)
Platelet Count Decreased
63 (.34%)
White Blood Cell Count Decreased
63 (.34%)
Hyperhidrosis
62 (.34%)
Injection Site Pain
62 (.34%)
Atrial Fibrillation
61 (.33%)
Hypoaesthesia
61 (.33%)
Muscular Weakness
61 (.33%)
Disseminated Intravascular Coagulat...
60 (.33%)
Liver Disorder
60 (.33%)
Oedema Peripheral
60 (.33%)
Asthma
59 (.32%)
Neutropenia
59 (.32%)
Back Pain
58 (.32%)
Depression
58 (.32%)
General Physical Health Deteriorati...
58 (.32%)
Drug Interaction
57 (.31%)
Psychotic Disorder
57 (.31%)
Septic Shock
57 (.31%)
Acute Respiratory Distress Syndrome
55 (.3%)
Staphylococcal Infection
55 (.3%)
Weight Increased
54 (.3%)
Cardio-respiratory Arrest
53 (.29%)
Drug Hypersensitivity
53 (.29%)
Fall
53 (.29%)
Cytomegalovirus Infection
51 (.28%)
Drug Exposure During Pregnancy
51 (.28%)
Paraesthesia
51 (.28%)
Arthralgia
49 (.27%)
Coma
48 (.26%)
Pain In Extremity
48 (.26%)
Pneumocystis Jiroveci Pneumonia
48 (.26%)
Respiratory Distress
48 (.26%)
Cytolytic Hepatitis
47 (.26%)
Dehydration
47 (.26%)
Gastrointestinal Haemorrhage
47 (.26%)
Haemoglobin Decreased
46 (.25%)
Weight Decreased
46 (.25%)
Haemorrhage
45 (.25%)
Heart Rate Increased
45 (.25%)
Hypokalaemia
43 (.24%)
Lung Disorder
43 (.24%)
Hallucination
42 (.23%)
Blood Potassium Decreased
41 (.22%)
Bronchospasm
41 (.22%)
Pancytopenia
41 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Methylprednisolone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone Sodium Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Methylprednisolone Sodium Succinate

What are the most common Methylprednisolone Sodium Succinate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Methylprednisolone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Methylprednisolone Sodium Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Methylprednisolone Sodium Succinate According to Those Reporting Adverse Events

Why are people taking Methylprednisolone Sodium Succinate, according to those reporting adverse events to the FDA?

Premedication
1106
Multiple Sclerosis
425
Drug Use For Unknown Indication
400
Product Used For Unknown Indication
377
Asthma
220
Renal Transplant
196
Show More Show More
Multiple Sclerosis Relapse
174
Prophylaxis
146
Interstitial Lung Disease
125
Ill-defined Disorder
119
Rheumatoid Arthritis
79
Prophylaxis Against Graft Versus Ho...
76
Immunosuppression
72
Prophylaxis Against Transplant Reje...
65
Graft Versus Host Disease
63
Chronic Obstructive Pulmonary Disea...
61
Crohns Disease
51
Pneumonia
50
Severe Acute Respiratory Syndrome
48
Juvenile Arthritis
44
Prophylaxis Of Nausea And Vomiting
43
Colitis Ulcerative
42
Nausea
38
Lymphoma
38
Hypersensitivity
38
Acute Lymphocytic Leukaemia
37
Dyspnoea
35
Non-hodgkins Lymphoma
35
Dermatomyositis
35
Optic Neuritis
31
Systemic Lupus Erythematosus
31
Pain
31
Acute Respiratory Distress Syndrome
31
Immunosuppressant Drug Therapy
30
Nephrotic Syndrome
29
Transplant Rejection
27
Urticaria
26
Allergy Prophylaxis
25
Vomiting
25
Liver Transplant
25
Bone Marrow Conditioning Regimen
24
Status Asthmaticus
23
Rash
21
T-cell Lymphoma
20
Aplastic Anaemia
20
Kidney Transplant Rejection
20
Chemotherapy
20
Chronic Lymphocytic Leukaemia
20
Bronchitis
19
Breast Cancer
19
Shock
19

Drug Labels

LabelLabelerEffective
Methylprednisolone Sodium SuccinateBedford Laboratories08-DEC-09
Methylprednisolone Sodium SuccinateBedford Laboratories08-DEC-09
Solu-medrolCardinal Health03-MAY-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company01-JUN-12
Solu-medrolPharmacia and Upjohn Company02-JUL-12
Solu-medrolCardinal Health13-JUL-12
Methylprednisolone Sodium SuccinateAPP Pharmaceuticals, LLC31-AUG-12
Methylprednisolone Sodium SuccinateAPP Pharmaceuticals, LLC31-AUG-12
Solu-medrolREMEDYREPACK INC. 09-FEB-13
Methylprednisolone Sodium SuccinateCardinal Health13-MAR-13
Solu-medrolCardinal Health20-MAR-13
Solu-medrolCardinal Health04-APR-13
Solu-medrolREMEDYREPACK INC. 15-APR-13

Methylprednisolone Sodium Succinate Case Reports

What Methylprednisolone Sodium Succinate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Methylprednisolone Sodium Succinate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Methylprednisolone Sodium Succinate.